Bengaluru: Biocon executive chairperson Kiran Mazumdar Shaw has tested positive for COVID-19.
Shaw informed this in a tweet on Monday night.
Biocon was recently in the news for making the controversial drug Itolizumab.
In July, Shaw claimed that Itolizumab had been approved in India and since the country was in a medical emergency, it was decided to go ahead with a clinical trial involving a cohort of 30 patients.’
She had further said the regulatory process was extremely robust and the scientific discussions on the trial were of a very high order.
Bhubaneswar: With the budget session of the Odisha Assembly scheduled to commence on February 13,…
Mumbai: The Jalgaon train accident was the result of a ‘sheer rumour’ about fire spread…
Jammu: After a mysterious illness in Jammu and Kashmir claimed at least 17 lives in…
Sundargarh: In a tragic incident, a 12-year-old girl died after she accidentally consumed rice laced…
New Delhi: On Netaji Subhas Chandra Bose’ birth anniversary, Anita Bose Pfaff, daughter of Netaji…
Bhubaneswar: At least four persons were injured and several vehicles damaged in a series of…
This website uses cookies.
